In 2019, Jazz Pharmaceuticals agreed to pay $57Mn for violating the US anti-kickback statute
Register to read the full analysis —or— Upgrade to access more features
#theft
#overdose
#drug abuse
#counterfeit
Actual Direct Impact
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue
There is no comment yet.